Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Current Leases (2021 - 2025)

Beauty Health (SKIN) has disclosed Current Leases for 5 consecutive years, with $5.1 million as the latest value for Q4 2025.

  • Quarterly Current Leases changed 0.37% to $5.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.1 million through Dec 2025, changed 0.37% year-over-year, with the annual reading at $5.1 million for FY2025, 0.37% changed from the prior year.
  • Current Leases for Q4 2025 was $5.1 million at Beauty Health, up from $5.0 million in the prior quarter.
  • The five-year high for Current Leases was $5.2 million in Q2 2025, with the low at $3.7 million in Q4 2021.
  • Average Current Leases over 5 years is $4.7 million, with a median of $4.9 million recorded in 2023.
  • The sharpest move saw Current Leases soared 33.57% in 2022, then decreased 12.71% in 2024.
  • Over 5 years, Current Leases stood at $3.7 million in 2021, then soared by 33.57% to $5.0 million in 2022, then decreased by 7.26% to $4.6 million in 2023, then rose by 11.94% to $5.1 million in 2024, then dropped by 0.37% to $5.1 million in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $5.1 million, $5.0 million, and $5.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.